Acellular fish skin grafts in the treatment of diabetic wounds: Advantages and clinical translation

Chenyu Zhao,Mengyi Feng,Martin Gluchman,Xianghe Ma,Jinhao Li,Hui Wang
DOI: https://doi.org/10.1111/1753-0407.13554
IF: 4.53
2024-04-27
Journal of Diabetes
Abstract:Highlights Concisely included the latest research on the role of acellular fish skin grafts (AFSGs) in treating diabetic wounds, providing readers with a basic framework, This review outlined the therapeutic advantages and prospects of AFSGs, This work emphasized the role of cost‐effectiveness in the treatment of diabetic wound dressings. We summarized the shortcomings and corrective measures of current AFSGs clinical trials. We explored the resistance that may be encountered by AFSGs in various stages of clinical studies. Diabetic wounds cannot undergo normal wound healing due to changes in the concentration of hyperglycemia in the body and soon evolve into chronic wounds causing amputation or even death of patients. Diabetic wounds directly affect the quality of patients and social medical management; thus researchers started to focus on skin transplantation technology. The acellular fish skin grafts (AFSGs) are derived from wild fish, which avoids the influence of human immune function and the spread of the virus through low‐cost decellularization. AFSGs contain a large amount of collagen and omega‐3 polyunsaturated fatty acids and they have an amazing effect on wound regeneration. However, after our search in major databases, we found that there were few research trials in this field, and only one was clinically approved. Therefore, we summarized the advantages of AFSGs and listed the problems faced in clinical use. The purpose of this paper is to enable researchers to better carry out original experiments at various stages.
endocrinology & metabolism
What problem does this paper attempt to address?